Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

Inclusion Criteria: * patients with HCC (Ia, Ib, IIa stage) China liver cancer staging who underwent resection or ablation * without macro-vascular invasion * Child-Pugh A/B grade * HCC is proved by pathological examination or two enhanced imaging * CEUS (Sonovue or Sonozoid) images are performed two weeks before the operation * Invasive biomarker or prognosis of HCC available * CEUS images are included in at least three stages (Arterial phase, Portal phase, and Late phase) Exclusion Criteria: * postop follow-up loss or expired less than 3 months * patients with co-malignancy * poor images quality for analyzing